Droia Oncology Ventures
Investor type
VC
Last fund created
2011
AUM
-
Location
Luxembourg
$1-5 m
Investment Ticket
3-5 years
Investment Horizon
Seed,
Series A
Investment Stage
Sale to strategic investor,
IPO
Exit Strategy
Profile
Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients. We are specialists, investing exclusively in therapeutics for oncology and genetic disease. Our focus and our in-house team of drug development experts and biotech professionals allow us to accelerate our companies’ progress by actively supporting them from company creation through clinical proof of concept. We are hands-on investors and entrepreneurs, fully dedicated to making an impact and saving patient lives.
Industry
Region of investment
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!